EGF receptor ligands - PubMed (original) (raw)

Review

EGF receptor ligands

Raymond C Harris et al. Exp Cell Res. 2003.

No abstract available

PubMed Disclaimer

Similar articles

• The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.
  Lenferink AE, De Roos AD, Van Vugt MJ, Van de Poll ML, Van Zoelen EJ. Lenferink AE, et al. Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):147-51. doi: 10.1042/bj3360147. Biochem J. 1998. PMID: 9806896 Free PMC article.
• Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
  Elleman TC, Domagala T, McKern NM, Nerrie M, Lönnqvist B, Adams TE, Lewis J, Lovrecz GO, Hoyne PA, Richards KM, Howlett GJ, Rothacker J, Jorissen RN, Lou M, Garrett TP, Burgess AW, Nice EC, Ward CW. Elleman TC, et al. Biochemistry. 2001 Jul 31;40(30):8930-9. doi: 10.1021/bi010037b. Biochemistry. 2001. PMID: 11467954
• Binding specificities and affinities of egf domains for ErbB receptors.
  Jones JT, Akita RW, Sliwkowski MX. Jones JT, et al. FEBS Lett. 1999 Mar 26;447(2-3):227-31. doi: 10.1016/s0014-5793(99)00283-5. FEBS Lett. 1999. PMID: 10214951
• Multidomain binding of transforming growth factor alpha to the epidermal growth factor receptor.
  Richter A, Conlan JW, Ward ME, Chamberlin SG, Alexander P, Richards NG, Davies DE. Richter A, et al. Biochemistry. 1992 Oct 13;31(40):9546-54. doi: 10.1021/bi00155a006. Biochemistry. 1992. PMID: 1390737
• TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
  Lee DC, Sunnarborg SW, Hinkle CL, Myers TJ, Stevenson MY, Russell WE, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Chang A, Jackson LF. Lee DC, et al. Ann N Y Acad Sci. 2003 May;995:22-38. doi: 10.1111/j.1749-6632.2003.tb03207.x. Ann N Y Acad Sci. 2003. PMID: 12814936 Review.

Cited by

• Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
  Tawengi M, Al-Dali Y, Tawengi A, Benter IF, Akhtar S. Tawengi M, et al. Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review.
• The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway.
  Wilson PG, Abdelmoti L, Gao T, Galperin E. Wilson PG, et al. Hum Mol Genet. 2024 Sep 3;33(18):1592-1604. doi: 10.1093/hmg/ddae100. Hum Mol Genet. 2024. PMID: 38881369
• Proteomics appending a complementary dimension to precision oncotherapy.
  Zhou Z, Zhang R, Zhou A, Lv J, Chen S, Zou H, Zhang G, Lin T, Wang Z, Zhang Y, Weng S, Han X, Liu Z. Zhou Z, et al. Comput Struct Biotechnol J. 2024 Apr 20;23:1725-1739. doi: 10.1016/j.csbj.2024.04.044. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38689716 Free PMC article. Review.
• Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer.
  Yue F, Ku AT, Stevens PD, Michalski MN, Jiang W, Tu J, Shi Z, Dou Y, Wang Y, Feng XH, Hostetter G, Wu X, Huang S, Shroyer NF, Zhang B, Williams BO, Liu Q, Lin X, Li Y. Yue F, et al. bioRxiv [Preprint]. 2024 Jan 11:2024.01.10.574969. doi: 10.1101/2024.01.10.574969. bioRxiv. 2024. PMID: 38260423 Free PMC article. Preprint.
• IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through Src-mediated upregulation of EREG in oral cancer.
  Lin CW, Yang WE, Su CW, Lu HJ, Su SC, Yang SF. Lin CW, et al. Int J Biol Sci. 2024 Jan 1;20(3):818-830. doi: 10.7150/ijbs.91786. eCollection 2024. Int J Biol Sci. 2024. PMID: 38250159 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations